Serotiny, Inc. — Form D
Serotiny, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-20. The offering totals $4.5M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-20
- Form: D
- Accession: 0001745734-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.0M
- Remaining: $500K
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2023-03-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-476382
Issuer
- Name: Serotiny, Inc.
- CIK: 0001745734
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 329 Oyster Point Boulevard, SAN FRANCISCO, CA, 94080
- Phone: 415-742-1139
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Colin Farlow | Director | San Francisco, CA |
| Justin Farlow | Director | San Francisco, CA |
| Eric Moessinger | Director | San Francisco, CA |
| Colin Farlow | Executive Officer | San Francisco, CA |
| Justin Farlow | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More